Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer

NCT06196671 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT06196671
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06196671 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer
Lead sponsor
Fudan University
Phase
Phase 2
Overall status
Not yet recruiting
Start date
December 1, 2026
Completion date
January 1, 2028
Enrollment
30 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic cancer